Código QR (código de barras bidimensional)

Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes

AimTo evaluate the treatment effect Fand pharmacoeconomic value of Dugaglutide in women with type 2 diabetes.MethodsWomen (n=96) with type 2 diabetes recruited from June 2019 to December 2021 were randomized into two equal groups. The control group was treated with Liraglutide, and the observation g...

ver descrição completa

Na minha lista:
Principais autores: Yu Su, Shuo Zhang, Zezhen Wu, Weiting Liu, Jingxian Chen, Feiying Deng, Fengwu Chen, Dan Zhu, Kaijian Hou
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2023-01-01
coleção:Frontiers in Endocrinology
Assuntos:
Dulaglutide
type 2 diabetes
treatment effect
pharmacoeconomics
insulin resistance index
cost-effectiveness ratio
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fendo.2023.1054946/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados